Top Markets
#1 0G 0G +38.62%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.25%
#3 Useless Coin Useless Coin +34.12%
#4 StonkBroker StonkBroker +31.74%
#5 Arbitrum Arbitrum +31.19%
#6 SAFEcoin SAFEcoin +28.71%
#7 Notcoin Notcoin +19.84%
#8 Pons Pons +18.99%
#9 Full Moon Full Moon +18.20%
#10 Curve DAO Curve DAO +16.10%
Coin of the day
0G 0G
Settings
Language
ENGLISH
Currency
USD
Theme
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rank in Stocks #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Share Price
$0.88012714
Market Cap
$439.58M
Change (1 day)
-4.01%
Change (1 year)
1,130.75%
Country
FR
Trade Valerio Therapeutics S.A. (ALVIO)

Category

Healthcare
Earnings for Valerio Therapeutics S.A. (ALVIO)
Earnings in 2026 TTM: 0
According to Valerio Therapeutics S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Valerio Therapeutics S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH